Drugs / Pyrantel Pamoate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial · 1 met primary | ||||||
| Phase 4 | NCT03278431 | Sep → Nov 2017 | hookworm infectious disease | Swiss Tropical & Public Health Institute | Completed | Met primary |
| Comparator or background therapy1 trial | ||||||
| — | NCT02812615 Background | Jul 2016 → Jun 2022 | infectious disease, protein-energy malnutrition | International Centre for Diarrhoeal Disease Research, Bangladesh | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pyrantel Pamoate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02812615 ↗ |